Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an ...

Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an ...

Researchers at the Icahn School of Medicine have unveiled the AMETA Nanobody Platform, which effectively combats SARS-CoV-2 ...

Within two to four weeks after HIV infection, many, but not all, people develop flu-like symptoms, including fever, swollen ...

Llama Nanobodies: A Breakthrough in Building HIV Immunity July 17, 2024 — Biology researchers have developed a new antibody therapy that can neutralize a wide variety of HIV-1 strains.

HIV Research for Prevention Conference ANALYSIS | SETHI NCUBE | The 5th HIV Research for Prevention Conference (HIVR4P 2024) ...

Researchers at Fred Hutchinson Cancer Center, led by Dr. Julie McElrath, Director of the Vaccine and Infectious Disease Division, have found a new way to train our immune system to make antibodies ...

Patients with osteoarthritis (OA) of the knee receiving an investigational chemokine inhibitor showed some improvements in ...

The 5th HIV Research for Prevention Conference (HIVR4P 2024) held in Lima, Peru, marked a significant milestone in the global ...

Harmony Garges, M.D, senior vice president, chief medical officer and head of global medical at ViiV Healthcare, highlighted ...

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for people like Anna Engomba, the arrival of new, life-saving medication cannot ...

Planned industry first clinical trial combining BeiGene's checkpoint inhibitor tislelizumab with Indaptus’ broadly targeted, short duration ...